Bottom line
What does XBI hold?
XBI held 161 positions as of Jun 30, 2026. Its largest holding is State Street Global Advisors at 5.87% of the fund, and the top 10 positions add up to 18%. By asset type it is 0% equity derivatives, 100% stocks, 6% cash & short-term funds.
Updated Aug 28, 2026
XBI top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | State Street Global Advisors State Street Navigator Securities Lending Portfolio II |
Cash & short-term funds | 5.87% | $630.6M |
| 2 | Apogee Therapeutics Inc | Stocks | 1.49% | $159.8M |
| 3 | Moderna Inc | Stocks | 1.41% | $151.6M |
| 4 | Twist Bioscience Corp | Stocks | 1.41% | $151.1M |
| 5 | Oruka Therapeutics Inc | Stocks | 1.38% | $148.0M |
| 6 | Kymera Therapeutics Inc | Stocks | 1.36% | $145.9M |
| 7 | Viking Therapeutics Inc | Stocks | 1.30% | $140.0M |
| 8 | Praxis Precision Medicines Inc | Stocks | 1.29% | $138.5M |
| 9 | Erasca Inc | Stocks | 1.27% | $136.4M |
| 10 | Revolution Medicines Inc | Stocks | 1.20% | $129.3M |
| 11 | Rhythm Pharmaceuticals Inc | Stocks | 1.20% | $129.0M |
| 12 | CG oncology Inc | Stocks | 1.20% | $128.8M |
| 13 | SELLAS Life Sciences Group Inc | Stocks | 1.19% | $127.7M |
| 14 | Vaxcyte Inc | Stocks | 1.19% | $127.4M |
| 15 | Dianthus Therapeutics Inc | Stocks | 1.18% | $127.0M |
| 16 | Cytokinetics Inc | Stocks | 1.18% | $126.5M |
| 17 | Natera Inc | Stocks | 1.16% | $124.8M |
| 18 | Scholar Rock Holding Corp | Stocks | 1.16% | $124.2M |
| 19 | Roivant Sciences Ltd | Stocks | 1.16% | $124.0M |
| 20 | Mirum Pharmaceuticals Inc | Stocks | 1.16% | $124.0M |
| 21 | Cogent Biosciences Inc | Stocks | 1.14% | $122.8M |
| 22 | Ultragenyx Pharmaceutical Inc | Stocks | 1.14% | $122.4M |
| 23 | Travere Therapeutics Inc | Stocks | 1.13% | $121.0M |
| 24 | Alkermes PLC | Stocks | 1.11% | $119.0M |
| 25 | Krystal Biotech Inc | Stocks | 1.10% | $118.5M |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 28, 2026